Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim F Oberlander

Showing results (71-80 of 172) with videos related to

Pageof 18
Sort By:
Pediatrics|September 30, 2009
Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitorsJodi L Pawluski, Liisa A M Galea, Ursula Brain, et al.
The Journal of Clinical Psychiatry|March 9, 2004
Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposureTim F Oberlander, Shaila Misri, Colleen E Fitzgerald, et al.
Pediatrics|February 3, 2005
Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposureTim F Oberlander, Ruth Eckstein Grunau, Colleen Fitzgerald, et al.
Depression and Anxiety|June 20, 2013
Factors impacting decisions to decline or adhere to antidepressant medication in perinatal women with mood and anxiety disordersShaila Misri, Andrea B Eng, Jasmin Abizadeh, et al.
Infant Behavior & Development|June 4, 2013
The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of ageWhitney M Weikum, Linda C Mayes, Ruth E Grunau, et al.
Archives of Pediatrics & Adolescent Medicine|January 3, 2007
Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancyTim F Oberlander, Pratibha Reebye, Shaila Misri, et al.
Journal of Psychiatric Research|December 5, 2020
Antidepressant exposure in pregnancy and child sensorimotor and visuospatial developmentMegan Galbally, Stuart J Watson, Olav Spigset, et al.
Archives of Women'S Mental Health|June 26, 2012
Biopsychosocial determinants of treatment outcome for mood and anxiety disorders up to 8 months postpartumShaila Misri, Gillian Albert, Jasmin Abizadeh, et al.
The Clinical Journal of Pain|February 11, 2004
Does prone or supine position influence pain responses in preterm infants at 32 weeks gestational age?Ruth Eckstein Grunau, Maria Beatriz Martins Linhares, Liisa Holsti, et al.
Psychoneuroendocrinology|December 20, 2011
Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA functionJodi L Pawluski, Ursula M Brain, Caroline M Underhill, et al.
Pageof 18

Showing results (71-80 of 172) with videos related to

Sort By:
Pageof 18
Pediatrics|September 30, 2009
Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitorsJodi L Pawluski, Liisa A M Galea, Ursula Brain, et al.
The Journal of Clinical Psychiatry|March 9, 2004
Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposureTim F Oberlander, Shaila Misri, Colleen E Fitzgerald, et al.
Pediatrics|February 3, 2005
Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposureTim F Oberlander, Ruth Eckstein Grunau, Colleen Fitzgerald, et al.
Depression and Anxiety|June 20, 2013
Factors impacting decisions to decline or adhere to antidepressant medication in perinatal women with mood and anxiety disordersShaila Misri, Andrea B Eng, Jasmin Abizadeh, et al.
Infant Behavior & Development|June 4, 2013
The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of ageWhitney M Weikum, Linda C Mayes, Ruth E Grunau, et al.
Archives of Pediatrics & Adolescent Medicine|January 3, 2007
Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancyTim F Oberlander, Pratibha Reebye, Shaila Misri, et al.
Journal of Psychiatric Research|December 5, 2020
Antidepressant exposure in pregnancy and child sensorimotor and visuospatial developmentMegan Galbally, Stuart J Watson, Olav Spigset, et al.
Archives of Women'S Mental Health|June 26, 2012
Biopsychosocial determinants of treatment outcome for mood and anxiety disorders up to 8 months postpartumShaila Misri, Gillian Albert, Jasmin Abizadeh, et al.
The Clinical Journal of Pain|February 11, 2004
Does prone or supine position influence pain responses in preterm infants at 32 weeks gestational age?Ruth Eckstein Grunau, Maria Beatriz Martins Linhares, Liisa Holsti, et al.
Psychoneuroendocrinology|December 20, 2011
Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA functionJodi L Pawluski, Ursula M Brain, Caroline M Underhill, et al.
Pageof 18